Stanley Laman Group, Ltd. Dexcom Inc Transaction History

Stanley Laman Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$84.79 - $104.74 $1.4 Million - $1.73 Million	-16,523 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$78.0 - $104.5 $82,992 - $111,188	1,064 Added 6.88%	16,523 $6.11 Million
Q3 2020 Oct 20, 2020	BUY	$95.51 - $112.95 $46,131 - $54,554	483 Added 3.23%	15,459 $6.37 Million
Q2 2020 Jul 20, 2020	BUY	$62.68 - $105.34 $938,695 - $1.58 Million	14,976 New	14,976 $6.07 Million
Q3 2019 Nov 08, 2019	SELL	$35.53 - $43.8 $77,206 - $95,177	-2,173 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$27.84 - $38.92 $60,496 - $84,573	2,173 New	2,173 $326,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.